Quantitative proteomics of the aging synapse: protein turnover and aggregation in neurodegeneration¶

Notebook ID: nb-SDA-2026-04-16-frontier-proteomics-1c3dba72 · Analysis: SDA-2026-04-16-frontier-proteomics-1c3dba72
Domain: proteomics · Date: 2026-04-16

Research Question¶

How does synaptic protein turnover change with age and neurodegeneration, and what role does impaired protein homeostasis play in synaptic dysfunction? Specifically, how do ubiquitin-proteasome and autophagy-lysosome pathways fail in aging synapses, leading to accumulation of misfolded proteins and synaptic degeneration in Alzheimer's and related dementias?

Debate Summary¶

Quality score: N/A · Rounds: 4

Round 1¶

Therapeutic Hypotheses: Synaptic Protein Turnover in Aging & Neurodegeneration¶

Hypothesis 1: TFEB Activation to Restore Lysosomal Biogenesis in Aged Synapses¶

Title: Small-molecule TFEB activation to overcome autophagosome-lysosome fusion deficits in Alzheimer's synapses

Description: The transcription factor EB (TFEB) is the master regulator of lysosomal biogenesis and autophagy gene expression. In aging neurons and Alzheimer's disease, TFEB nuclear translocation is impaired due to mTOR overactivation and impaired calcium signaling. Pharmacological TFEB activation using rapamycin analogs or direct TFEB agonists (e.g., trehalose, genistein) could restore lysosomal gene expression in synapses, increasing levels of V-ATPase, cathepsins, and autophagosome-lysosome fusion

Round 2¶

Critical Evaluation of Synaptic Proteostasis Therapeutic Hypotheses¶

Hypothesis 1: TFEB Activation to Restore Lysosomal Biogenesis¶

Weaknesses in Evidence¶

1. Pleiotropic transcriptional effects TFEB regulates hundreds of genes beyond lysosomal biogenesis, including lipid metabolism genes (PPARG, PLIN2), inflammatory pathways, and extracellular matrix remodeling genes. The literature cited (PMID: 25661182) shows cellular model validation, but these systems lack the complexity of aged human synapses where off-target transcriptional programs could dysregulate synaptic transmission.

2. mTOR-TFEB relationship is context-dependent The claim that "mTOR overactivation" impairs TFEB nuclear translocation is oversimplified. Recent evidence demonstrates that synaptic activity its

Round 3¶

Drug Development Feasibility Analysis: Synaptic Proteostasis Hypotheses¶

Executive Summary¶

All seven hypotheses target mechanistically plausible nodes in synaptic proteostasis, but face significant translational barriers. The fundamental challenge is that proteostasis networks are highly interconnected—single-node interventions trigger compensatory responses that may negate therapeutic benefit. The revised confidence scores in the skeptic critique are scientifically justified: mean original confidence (0.64) drops to 0.40 after critique, reflecting legitimate concerns about compound specificity, delivery challenges, and potential maladaptive compensation.

Hypothesis 1: TFEB Activation¶

Druggability Assessment: MODERATE¶

TFEB is a transcription factor (intrinsically

Round 4¶

{
  "ranked_hypotheses": [
    {
      "rank": 1,
      "id": "H1",
      "title": "TFEB Activation to Restore Lysosomal Biogenesis in Aged Synapses",
      "target": "TFEB (TFE3, TFE4 family)",
      "confidence": 0.5733,
      "scores": {
        "mechanistic_plausibility": 0.75,
        "evidence_strength": 0.60,
        "novelty": 0.55,
        "feasibility": 0.55,
        "therapeutic_potential": 0.70,
        "druggability": 0.50,
        "safety_profile": 0.45,
        "competitive_landscape": 0.55,
        "data_availability": 0.60,
        "reproducibility": 0.55
      },
      "evidence_for": [
        {"claim": "TFEB overexpression reduces tau aggregation and Aβ toxicity in cellular models", "pmid": "25661182"},
        {"claim": "Impaired TFEB nuclear localization obs

Hypotheses Ranked by Composite Score¶

Total hypotheses: 7

Title	Composite	Confidence	Novelty	Feasibility	Impact
TFEB Activation to Restore Lysosomal Biogenesis in Aged Synapses	0.533	0.573	0.55	0.55	0.7
VPS35 Retromer Restoration to Rescue Endosomal Protein Trafficking	0.506	0.532	0.55	0.55	0.6
USP14 Inhibition to Accelerate Proteasomal Degradation of Synaptic Substrates	0.481	0.458	0.55	0.55	0.55
CHIP E3 Ligase Enhancement to Target Synaptic Proteins for Degradation	0.472	0.473	0.65	0.45	0.55
Hsp70 cochaperone BAG3-mediated Autophagy Activation for Synaptic Protein Qualit	0.469	0.472	0.65	0.4	0.55
Cathepsin D Replacement to Overcome Lysosomal Protease Deficiency	0.457	0.478	0.55	0.4	0.55
Synaptic-Selective Autophagy Receptor Expression to Bypass Axonal Lysosome Defic	0.416	0.397	0.7	0.35	0.4

Knowledge Graph Edges¶

Total edges: 29

Source	Relation	Target	Evidence
TFEB	transcription_factor_regulates	lysosomal_biogenesis	0.5
TFEB	transcription_factor_regulates	V-ATPase	0.5
TFEB	transcription_factor_regulates	cathepsins	0.5
mTOR	hyperactive_in	AD_brain	0.5
mTOR	phosphorylates	TFEB_Ser211	0.5
Aβ_oligomers	accumulates_at	synaptic_terminals	0.5
phosphorylated_tau	accumulates_at	synaptic_terminals	0.5
USP14	associated_with	19S_proteasome	0.5
USP14	removes_ubiquitin_from	proteasome_substrates	0.5
ubiquitinated_proteins	accumulates_in	AD_hippocampus	0.5
BAG3	interacts_with	p62/SQSTM1	0.5
BAG3	recruits_Hsc70_clients_to	autophagosomes	0.5
BAG3	decreased_expression_in	aged_neurons	0.5
p62	accumulates_in	AD_synapses	0.5
CHIP/STUB1	ubiquitinates	phosphorylated_tau	0.5
CHIP/STUB1	ubiquitinates	mutant_APP	0.5
CHIP/STUB1	reduced_levels_in	AD_temporal_cortex	0.5
Hsp70	cooperates_with	CHIP/STUB1	0.5
VPS35	mutations_cause	familial_Parkinson's_disease	0.5
VPS35	reduced_in	AD_hippocampus	0.5

Key Citations¶

No citations found for this analysis.

View analysis on SciDEX · Browse all analyses · Browse notebooks

Quantitative proteomics of the aging synapse: protein turnover and aggregation in neurodegeneration — Analysis Notebook

Notebook Overview